相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Smart drug delivery of p-Coumaric acid loaded aptamer conjugated starch nanoparticles for effective triple-negative breast cancer therapy
Arokia Vijaya Anand Mariadoss et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT
Yihui Zhu et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Amorphophalli Rhizoma inhibits breast cancer growth, proliferation, migration, and invasion via the PI3K/AKT pathway
Hailong Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
Sara G. Manore et al.
FRONTIERS IN ONCOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Remodeling the ECM: Implications for Metastasis and Tumor Dormancy
Julie S. Di Martino et al.
CANCERS (2021)
CD45 Immunohistochemistry in Mouse Kidney
Shirong Zheng et al.
BIO-PROTOCOL (2021)
Icariin induces apoptosis in breast cancer MCF-7 cells by regulating the MELK mediated PI3K/AKT signaling pathway
Danping Qian et al.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY (2021)
Notch3 promotes prostate cancer-induced bone lesion development via MMP-3
Sourik S. Ganguly et al.
ONCOGENE (2020)
Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways
Tian Wei et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9
Xinxin Zhang et al.
BONE (2020)
5-Hydroxymethyl-Furfural and Structurally Related Compounds Block the Ion Conductance in Human Aquaporin-1 Channels and Slow Cancer Cell Migration and Invasion
Pak Hin Chow et al.
MOLECULAR PHARMACOLOGY (2020)
Clinical observation on the effect of Chinese medicine-TCM formula intervention on recurrence and metastasis of triple negative breast cancer
Yi Wang et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2020)
Vanillic Acid Improves Comorbidity of Cancer and Obesity through STAT3 Regulation in High-Fat-Diet-Induced Obese and B16BL6 Melanoma-Injected Mice
Jinbong Park et al.
BIOMOLECULES (2020)
Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer
Linjiang Song et al.
CANCER SCIENCE (2020)
Sodium Danshensu Inhibits Oral Cancer Cell Migration and Invasion by Modulating p38 Signaling Pathway
V. Bharath Kumar et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Magnoflorine-Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells
Estera Okon et al.
BIOMOLECULES (2020)
Genomic and GeneChip expression profiling reveals the inhibitory effects of Amorphophalli Rhizoma in TNBC cells
Chunyu Wu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Jiang-Jiang Qin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM
Xia Cheng et al.
BREAST CANCER (2019)
MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway
Lin Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer
Xueni Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
STAT3 Targets ERR-α to Promote Epithelial-Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells
Jia-Hui Ma et al.
MOLECULAR CANCER RESEARCH (2019)
Targeted Therapies for Triple-Negative Breast Cancer
Tomas G. Lyons
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Syntenin1/MDA-9 (SDCBP) induces immune evasion in triple-negative breast cancer by upregulating PD-L1
Jing Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
Varun Sasidharan Nair et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Bt354 as a new STAT3 signaling pathway inhibitor against triple negative breast cancer
Yue Chen et al.
JOURNAL OF DRUG TARGETING (2018)
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer
Hui Guo et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2018)
Triple-negative breast cancers - a panoply of cancer types
Fresia Pareja et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Icariin abrogates osteoclast formation through the regulation of the RANKL-mediated TRAF6/NF-kappa B/ERK signaling pathway in Raw264.7 cells
Buyun Kim et al.
PHYTOMEDICINE (2018)
Metastatic and triple-negative breast cancer: challenges and treatment options
Sumayah Al-Mahmood et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis
Marilena Tauro et al.
CANCERS (2018)
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
Hao Huang
SENSORS (2018)
A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
Wenda Zhang et al.
CELL DEATH & DISEASE (2018)
The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer
Mohammad W. Khan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro
Zhang-Feng Zhong et al.
ONCOLOGY REPORTS (2017)
Furanodiene enhances the anti-cancer effects of doxorubicin on ERα-negative breast cancer cells in vitro
Zhang-Feng Zhong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models
Seung-Hee Kim et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Rac1 modulates the formation of primordial follicles by facilitating STAT3-directed Jagged1, GDF9 and BMP15 transcription in mice
Lihua Zhao et al.
SCIENTIFIC REPORTS (2016)
Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer
Beomseok Son et al.
SCIENTIFIC REPORTS (2016)
Traditional Chinese medicine and cancer: History, present situation, and development
Jie Liu et al.
THORACIC CANCER (2015)
Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro
Zhangfeng Zhong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Anticancer Activity of Protocatechualdehyde in Human Breast Cancer Cells
Jieun Choi et al.
JOURNAL OF MEDICINAL FOOD (2014)
Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
Marta Bonotto et al.
ONCOLOGIST (2014)
Systematic screening and characterization of the major bioactive components of Poria cocos and their metabolites in rats by LC-ESI-MSn
Yun Ling et al.
BIOMEDICAL CHROMATOGRAPHY (2012)
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up
L. Malorni et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases
Patrick J. Medina et al.
CLINICAL THERAPEUTICS (2008)
Small molecule inhibitors of Stat3 signaling pathway
Jinxia Deng et al.
CURRENT CANCER DRUG TARGETS (2007)